https://thescriptpad.com/articles/ama-interim-meeting-2026-ai-licensure-downcoding-emergency-department-policies.htmlThe Script Paden2026-11-11T10:30:00-05:00What the AMA's House of Delegates Decided in Orlando, From AI Licensure to Downcoded Claims https://thescriptpad.com/articles/fda-approves-pimicotinib-pimjetmi-tgct-third-csf-1r-inhibitor-once-daily.htmlThe Script Paden2026-11-11T10:20:00-05:00Pimicotinib Gives Tenosynovial Giant Cell Tumor a Third Oral Drug, and the First Taken Once a Day https://thescriptpad.com/articles/attain-osa-orforglipron-sleep-apnea-jama-vs-tirzepatide-surmount-osa.htmlThe Script Paden2026-11-11T10:10:00-05:00How Does Oral Orforglipron Compare With Tirzepatide for Obstructive Sleep Apnea? https://thescriptpad.com/articles/va-oig-2026-severe-physician-shortages-17-specialties-135-of-139-facilities.htmlThe Script Paden2026-11-11T10:00:00-05:00Seventeen Physician Specialties Are Now Severe Shortages at One in Five VA Facilities or More https://thescriptpad.com/articles/cdc-ebola-entry-ban-eighth-order-nov-10-congo-10879-cases-kenya-nigeria.htmlThe Script Paden2026-11-11T09:50:00-05:00The CDC's Ebola Entry Ban Reaches Its Eighth Order in 176 Days, Still Limited to Three Countries https://thescriptpad.com/articles/fda-approves-asundexian-sunharbo-first-factor-xia-inhibitor-secondary-stroke-prevention.htmlThe Script Paden2026-11-10T10:30:00-05:00FDA Approves Asundexian as the First Factor XIa Inhibitor for Secondary Stroke Prevention https://thescriptpad.com/articles/fda-naion-warning-all-glp-1-labels-semaglutide-tirzepatide-ema-comparison.htmlThe Script Paden2026-11-10T10:20:00-05:00The FDA Adds an Optic Nerve Warning to All 12 GLP-1 Drug Labels and Stops Short of Europe's Advice https://thescriptpad.com/articles/rural-health-transformation-year-2-awards-68-million-shift-north-dakota-florida.htmlThe Script Paden2026-11-10T10:10:00-05:00Year Two of the Rural Health Fund Shifts $68 Million Among States, Less Than 1 Percent of the Total https://thescriptpad.com/articles/us-measles-cases-5182-exceed-2018-2025-combined-paho-elimination-review.htmlThe Script Paden2026-11-10T10:00:00-05:00This Year's 5,182 Measles Cases Exceed 2018 Through 2025 Combined. The Elimination Review Is Due This Month.